Chr | chr11 |
start | 1995176 |
end | 2001470 |
lncRNA name | H19 |
entrez id | 283120 |
hgnc id | HGNC:4713 |
ensg id | ENSG00000130600 |
refseq id | NR_002196 |
methods | qPCR, RNAi, Luciferase reporter assay, ISH etc. |
regulated | up-regulated |
function description | BCSCs express high levels of H19, and ectopic overexpression of H19 significantly promotes breast cancer cell clonogenicity, migration and mammosphere-forming ability. Conversely, silencing of H19 represses these BCSC properties. In concordance, knockdown of H19 markedly inhibits tumor growth and suppresses tumorigenesis in nude mice. Mechanistically, we found that H19 functions as a competing endogenous RNA to sponge miRNA let-7, leading to an increase in expression of a let-7 target, the core pluripotency factor LIN28, which is enriched in BCSC populations and breast patient samples. |
pubmed id | 28102845 |
year | 2017 |
title | H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. |
drug | X |
circulating | X |
survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China